AI MARKET SCANNING

Ligand Pharmaceuticals Incorpor

AVG HISTORICAL GAP +1.35%
MAX GAP RECORD +14.46%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $LGND
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 29, 2026 Earnings Release 2026-10-29 (UNDETERMINED)
+0.00%
Aug 06, 2026 Earnings Release 2026-08-06 (UNDETERMINED)
+0.00%
May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN)
-11.85%
Feb 26, 2026 Earnings Release 2026-02-26 (UNDETERMINED)
+0.00%
Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN)
+2.95%
Aug 07, 2025 Earnings Release 2025-08-07 (UNDETERMINED)
+0.00%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
+1.23%
Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN)
-2.84%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.5%
Bullish Gaps (7)
Bearish Gaps (3)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $LGND

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-20 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1168m +10.95%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗